11 November 2015 - Deborah Wilkes
Archived
LEO Pharma is set to acquire Astellas Pharma's global dermatology portfolio, including Locobase for treating dry skin, for €675 million (US$725 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.